Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

PharmAust Limited (F: ECQ)

 
ECQ Technical Analysis
4
As on 11th Jul 2023 ECQ STOCK Price closed @ 0.04 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.05 & Strong Sell for SHORT-TERM with Stoploss of 0.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ECQSTOCK Price

Open 0.04 Change Price %
High 0.04 1 Day 0.00 0.00
Low 0.04 1 Week 0.00 0.00
Close 0.04 1 Month 0.00 0.00
Volume 5 1 Year -0.02 -33.33
52 Week High 0.06 | 52 Week Low 0.03
 
F Germany Most Active Stocks
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
TOE 0.02 0.00%
 
F Germany Top Gainers Stocks
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
WPIA 6.22 871.88%
WPIA 6.22 871.88%
WPIA 6.22 871.88%
8S3B 1.73 620.83%
8S3B 1.73 620.83%
SY7P 0.07 600.00%
P9F1 1.75 326.83%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
AETG 0.25 -91.61%
AETG 0.25 -91.61%
 
 
ECQ
Daily Charts		 ECQ
Intraday Charts		 Whats New @
Bazaartrend		 ECQ
Free Analysis
 
ECQ Important Levels Intraday
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
RESISTANCE0.04
 
ECQ Forecast April 2024
Share
4th UP Forecast0.06
3rd UP Forecast0.05
2nd UP Forecast0.05
1st UP Forecast0.05
1st DOWN Forecast0.03
2nd DOWN Forecast0.03
3rd DOWN Forecast0.03
4th DOWN Forecast0.02
 
ECQ Weekly Forecast
4th UP Forecast0.06
3rd UP Forecast0.05
2nd UP Forecast0.05
1st UP Forecast0.05
1st DOWN Forecast0.03
2nd DOWN Forecast0.03
3rd DOWN Forecast0.03
4th DOWN Forecast0.02
 
ECQ Forecast2024
4th UP Forecast0.1
3rd UP Forecast0.08
2nd UP Forecast0.07
1st UP Forecast0.06
1st DOWN Forecast0.02
2nd DOWN Forecast0.01
3rd DOWN Forecast0
4th DOWN Forecast-0.02
 
 
ECQ Other Details
Segment EQ
Market Capital 20197296.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ECQ Address
ECQ
 
ECQ Latest News
 
Your Comments and Response on PharmAust Limited
 
ECQ Business Profile
PharmAust Limited, a clinical-stage company, develops targeted cancer therapeutics for humans and animals. The company develops drugs for the treatment of various cancers, and viral and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug for the treatment of cancer. PharmAust has completed Phase 1 clinical trials with monepantel in human and dog diagnosed with solid tumors, as well as initiated a Phase 2 pilot study in dogs diagnosed with Lymphoma. The company also provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries worldwide. The company has a research agreement with the Walter and Eliza Hall Institute to investigate the effects of MPL upon human T-lymphotrophic virus-1 (HTLV-1) infections in vitro. It serves drug discovery and pharmaceutical industries. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia. Address: 5/3 Brodie Hall Drive, Bentley, WA, Australia, 6102
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service